09.01.06
Sabinsa Corp., Piscataway, NJ, has been issued U.S. Patent No. 7,063,861 for the company’s Garcitrin ingredient. The patent, titled “Bioavailable Composition of Natural and Synthetic HCA,” covers the use of hydroxycitric acid (HCA) in combination with garcinol, branded Garcitrin, by Sabinsa Corp., for body composition and weight management. Garcitrin combines a distinct composition of HCA with garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica fruits. Garcinol enhances the biological action of HCA and contributes antioxidant activity to the formulation. The combination of calcium salt HCA and garcinol reduces fatty acid and lipid synthesis and improves lean body mass much more effectively than HCA alone.